A bipartisan coalition of 39 AGs sent a letter to Congressional leaders urging the swift passage of the Combatting Illicit Xylazine Act, which would provide resources to fight the recent uptick in overdoses and deaths caused by use of the street drug. Xylazine is manufactured for use as a non-opioid veterinary tranquilizer for large animals,…

Read More

2022 was a landmark year for state attorneys general.  From billion-dollar global settlements with players in each link of the opioids distribution chain to record-setting settlements with a tech giant, this past year AGs joined forces across the aisle to resolve disputes with some of the most prominent companies in the United States.

Read More

A group of 18 AGs reached agreements with CVS Health Corporation and CVS Pharmacy, Inc., and separately with Walgreens Co., to resolve allegations regarding the companies’ roles in contributing to the nationwide opioid crisis. The states have until the end of 2022 to formally join the agreements, which then will go to local governments for…

Read More

A group of 8 AGs reached agreements with Teva Pharmaceutical Industries Ltd. and Allergan Limited, as well as their respective affiliated entities, to resolve allegations regarding the companies’ roles in contributing to the nationwide opioid crisis. The Teva and Allergan settlements, the latest in a series of settlements between AGs and manufacturers, distributors, and retailers…

Read More

A group of 16 AGs reached a settlement with Walmart Inc., pending approval by the full coalition of 43 states, to resolve allegations regarding the company’s role in contributing to the nationwide opioid crisis. The settlement resolves allegations that Walmart pharmacies distributed and dispensed prescription opioid pain medication improperly. Under the terms of the settlement…

Read More